Semaglutide denied for failing step therapy by Humana?

Humana's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Applies Step Therapy to Semaglutide

Step therapy — sometimes called "fail-first" — means Humana requires documentation that a patient has tried and not succeeded with one or more less expensive or preferred drugs before it will cover semaglutide. For this drug class, step therapy requirements typically involve prior use of other agents within the same therapeutic category. A step-therapy denial does not mean you cannot get coverage; it means the submitted documentation did not yet demonstrate that the required prior steps were completed or that they are clinically inappropriate for you.

## Why This Denial Is Appealable

Step-therapy denials are among the most commonly overturned denials at appeal because documentation of prior therapy often exists in the chart but was not included in the original PA submission. Under ACA Section 2719 and ERISA Section 503, you have the right to an internal appeal and, if that is denied, an independent external review. Many states have also enacted step-therapy exception laws that require insurers to grant exceptions when required prior therapy is clinically contraindicated, was previously tried and failed, or would cause clinically significant harm. The external-review window is generally open for approximately four months from the denial date; expedited review (72-hour decision) is available for urgent cases.

## The Appeal Process

1. Identify the required step drugs — the denial letter or Humana's coverage policy must list the drugs you were required to have tried. 2. Compile trial history — gather records documenting each required drug that was tried, for how long, and why it was discontinued. 3. File the internal appeal with complete step-therapy documentation; confirm the deadline from your Explanation of Benefits. 4. Invoke state step-therapy exception law if applicable — your prescriber can attest that a required step drug is contraindicated or clinically inappropriate. 5. Escalate to external review if the internal appeal is denied.

## Documentation to Gather

• Step drug trial records: for each required prior drug, provide dates of initiation and discontinuation, dosing history, and clinical notes documenting the outcome (therapeutic failure, adverse effect, or prescriber-documented contraindication).
• Prescriber step-therapy exception letter: a letter from the prescriber explaining why each untried required step is clinically inappropriate for this patient, citing the applicable guideline organization (such as the ADA Standards of Care or Obesity Medicine Association guidelines) generically.
• Diagnosis and severity documentation: chart evidence demonstrating the current burden of illness and why initiating semaglutide now is medically necessary.

## Criteria-Mapping Structure

List every step-therapy requirement in Humana's policy. For each required prior drug, complete one row: "Required Drug / Tried? / Dates / Outcome or Clinical Exception Reason." An appeal that maps directly to each required step — with dated chart support or a prescriber exception attestation — gives the reviewer no basis to sustain the denial.